A-PRP® injections are simple and efficient, have minimal adverse effects with a
low cost-to-benefit ratio and can be regarded a valuable alternative for the
treatment of alopecia. 1-3

The effect of activated platelet-rich plasma injections on hair density through a 1-year period:

A significant increase in the rate of hair
growth was observed between the 3rd and
6th months. Hair density followed a rising
trend with a remarkable peak at 3 months.
Patients with II-III grade of alopecia had
better results compared to patients with
more advanced alopecia. 2

In a pilot study, which is the first to investigate the effects of PRP on AA, PRP was shown to significantly increase hair regrowth, to decrease hair dystrophy, burning and itching and to increase cell proliferation compared to reference treatments. These results suggest that PRP may serve as a safe and effective treatment option for alopecia areata. 4

A-PRP stimulates and supports hair growth after Follicular Unit Extraction (FUE) in three main steps:

  • Promoting vascularity to the hair root thereby increasing viability to the follicle before, during and after hair transplantation
  • Promoting tissue repair and regeneration post transplantation
  • Stimulating dormant hair follicles and growing new hair

1-Betsi E-E. et al. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. Eur J Plast Surg 2013: 36:407-12.
2-Gkini MA. et al. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7:213-9.
3-Borhan et al. Autologous Platelet Rich Plasma as a Treatment of Male Androgenetic Alopecia: Study of 14 cases. J CLin Exp Dermatol Res 2015, 6:4
4-Trink et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013 Sep;169(3):690-4

RegenKit BCT is CE Marked and is only available through authorized distributors. The Product has not been approved or cleared for marketing by the United States Food & Drug Administration.